D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 84 Citations 20,417 247 World Ranking 253 National Ranking 127

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Enzyme
  • Internal medicine

David S. Perlin mostly deals with Microbiology, Caspofungin, Echinocandin, Candida albicans and Drug resistance. His Microbiology study frequently links to other fields, such as Mutant. David S. Perlin has included themes like Etest, Mycosis, Micafungin and Susceptibility testing in his Caspofungin study.

In his study, Wild type, Candida parapsilosis and Enzyme is inextricably linked to Fungal protein, which falls within the broad field of Echinocandin. His Candida albicans research integrates issues from Molecular biology, Genotyping and Drug. His work carried out in the field of Drug resistance brings together such families of science as Fungal genetics, Antifungal drug, Gene and Candida auris.

His most cited work include:

  • Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure (575 citations)
  • Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations (479 citations)
  • Resistance to echinocandin-class antifungal drugs (401 citations)

What are the main themes of his work throughout his whole career to date?

David S. Perlin mainly investigates Microbiology, Echinocandin, Caspofungin, Candida albicans and Candida glabrata. His work in Drug resistance, Aspergillus fumigatus, Micafungin, Anidulafungin and Echinocandins are all subfields of Microbiology research. In his work, Aspergillosis is strongly intertwined with Aspergillus, which is a subfield of Aspergillus fumigatus.

His Echinocandin research is multidisciplinary, relying on both Candida parapsilosis, Drug, Azole, Fungal protein and In vivo. His research integrates issues of Fluconazole and Mutant in his study of Candida albicans. The concepts of his Candida glabrata study are interwoven with issues in Multiple drug resistance and Genotype.

He most often published in these fields:

  • Microbiology (56.21%)
  • Echinocandin (28.70%)
  • Caspofungin (20.12%)

What were the highlights of his more recent work (between 2018-2021)?

  • Microbiology (56.21%)
  • Echinocandin (28.70%)
  • Candida glabrata (15.09%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Microbiology, Echinocandin, Candida glabrata, Internal medicine and Fluconazole. Microbiology is represented through his Candida parapsilosis, Typing, Azole, Candida auris and Amphotericin B research. His Echinocandin study incorporates themes from Aspergillus, Caspofungin, Echinocandins, Enzyme and Drug resistance.

His research in Caspofungin focuses on subjects like Micafungin, which are connected to Pharmacology and Drug. His studies in Drug resistance integrate themes in fields like Mutant and Intensive care medicine. His Fluconazole research incorporates themes from Candida albicans and Corpus albicans.

Between 2018 and 2021, his most popular works were:

  • COVID-19 associated pulmonary aspergillosis (CAPA)—from immunology to treatment (56 citations)
  • Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients (34 citations)
  • Identification of Drug Resistant Candida auris. (30 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Enzyme
  • Internal medicine

David S. Perlin spends much of his time researching Microbiology, Echinocandin, Candida glabrata, Drug resistance and ARDS. His Microbiology research is multidisciplinary, incorporating elements of Microsatellite and Avibactam. His Echinocandin research incorporates elements of Minimum inhibitory concentration and CRISPR.

David S. Perlin has researched Candida glabrata in several fields, including Aspergillus fumigatus and Internal medicine, Incidence. His Drug resistance study combines topics from a wide range of disciplines, such as Candida auris, Aspergillus and Intensive care medicine. His work deals with themes such as Sphingolipid, Caspofungin, Echinocandins, Candida tropicalis and Enzyme, which intersect with Aspergillus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Barbara D. Alexander;Melissa D. Johnson;Christopher D. Pfeiffer;Cristina Jiménez-Ortigosa.
Clinical Infectious Diseases (2013)

743 Citations

Frequency and Evolution of Azole Resistance in Aspergillus fumigatus Associated with Treatment Failure

Susan J. Howard;Dasa Cerar;Michael J. Anderson;Ahmed Albarrag.
Emerging Infectious Diseases (2009)

732 Citations

Resistance to echinocandin-class antifungal drugs

David S. Perlin.
Drug Resistance Updates (2007)

572 Citations

Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates

S. Park;R. Kelly;J. Nielsen Kahn;J. Robles.
Antimicrobial Agents and Chemotherapy (2005)

425 Citations

The global problem of antifungal resistance: prevalence, mechanisms, and management

David S Perlin;Riina Rautemaa-Richardson;Ana Alastruey-Izquierdo.
Lancet Infectious Diseases (2017)

382 Citations

A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis Accounts for Reduced Echinocandin Susceptibility

Guillermo Garcia-Effron;Santosh K. Katiyar;Steven Park;Thomas D. Edlind.
Antimicrobial Agents and Chemotherapy (2008)

343 Citations

Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

M.A. Pfaller;D.J. Diekema;D. Andes;M.C. Arendrup.
Drug Resistance Updates (2011)

335 Citations

High-frequency Triazole Resistance Found In Nonculturable Aspergillus fumigatus from Lungs of Patients with Chronic Fungal Disease

David W. Denning;Steven Park;Cornelia Lass-Florl;Marcin G. Fraczek;Marcin G. Fraczek.
Clinical Infectious Diseases (2011)

318 Citations

Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-d-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

Guillermo Garcia-Effron;Samuel Lee;Steven Park;John D. Cleary.
Antimicrobial Agents and Chemotherapy (2009)

300 Citations

Mechanisms of Antifungal Drug Resistance

Leah E. Cowen;Dominique Sanglard;Susan J. Howard;P. David Rogers.
Cold Spring Harbor Perspectives in Medicine (2015)

297 Citations

Editorial Boards

Journal of Fungi
(Impact Factor: 5.724)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing David S. Perlin

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 115

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 111

David W. Denning

David W. Denning

University of Manchester

Publications: 104

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 92

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 80

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 70

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 68

Nathan P. Wiederhold

Nathan P. Wiederhold

The University of Texas Health Science Center at San Antonio

Publications: 63

Anuradha Chowdhary

Anuradha Chowdhary

University of Delhi

Publications: 63

Maurizio Sanguinetti

Maurizio Sanguinetti

Catholic University of the Sacred Heart

Publications: 62

Manuel Cuenca-Estrella

Manuel Cuenca-Estrella

Instituto de Salud Carlos III

Publications: 62

Willem J. G. Melchers

Willem J. G. Melchers

Radboud University Nijmegen

Publications: 62

Jesús Guinea

Jesús Guinea

Hospital General Universitario Gregorio Marañón

Publications: 56

Jean-Paul Latgé

Jean-Paul Latgé

Institut Pasteur

Publications: 55

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 54

Mariana Castanheira

Mariana Castanheira

JMI Laboratories

Publications: 54

Something went wrong. Please try again later.